Safety and efficacy of lenvatinib combined with camrelizumab plus transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: A two-center retrospective study.

导出 LinkOut

翻译打印收藏纠错

第一作者： Bo,Sun

第一单位： Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

作者： Bo,Sun ^[1] ; Lijie,Zhang ^[2] ; Tao,Sun ^[3] ; Yanqiao,Ren ^[1] ; Yanyan,Cao ^[2] ; Weihua,Zhang ^[3] ; Licheng,Zhu ^[1] ; Yusheng,Guo ^[2] ; Yuxi,Gui ^[3] ; Fengyong,Liu ^[1] ; Lei,Chen ^[2] ; Fu,Xiong ^[3] ; Chuansheng,Zheng ^[1]

作者单位： Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. ^[1] Key Laboratory of Molecular Imaging of Hubei Province, Wuhan, China. ^[2] Department of Interventional Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. ^[3] Department of Interventional Radiology, The Fifth Medical Center of Chinese, People's Liberation Army (PLA) General Hospital, Beijing, China. ^[4]

关键词 camrelizumab efficacy hepatocellular carcinoma lenvatinib safety transcatheter arterial chemoembolization

DOI 10.3389/fonc.2022.982948

PMID 36172158

发布时间 2022-09-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in oncology

2022年12卷

982948页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Safety and efficacy of lenvatinib combined with camrelizumab plus transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: A two-center retrospective study.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Safety and efficacy of lenvatinib combined with camrelizumab plus transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: A two-center retrospective study.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

检索历史清除